Publication	Data		Fish	Anatomy
Gou et al., 2018	Fig. 1		sox3x52/x52 (AB)	otic vesicle decreased size, abnormal
	Fig. 2		sox3x52/x52 (AB)	otic placode sox2 expression increased amount, abnormal otic placode sox2 expression increased distribution, abnormal
	Fig. 3		sox3x52/x52 (AB)	otic placode pax2a expression decreased distribution, abnormal otic placode pax8 expression decreased distribution, abnormal
	Fig. 4		sox3x52/x52 (AB)	facial ganglion phox2a expression absent, abnormal glossopharyngeal ganglion phox2a expression absent, abnormal vagal ganglion 1 phox2a expression decreased amount, abnormal vagal ganglion 1 phox2a expression decreased distribution, abnormal vagal ganglion 1 phox2a expression spatial pattern, abnormal vagal ganglion 2 phox2a expression decreased amount, abnormal vagal ganglion 2 phox2a expression decreased distribution, abnormal vagal ganglion 2 phox2a expression spatial pattern, abnormal
	Fig. 7		AB + MO3-sox3 + MO4-tp53	otic placode pax2a expression decreased amount, abnormal otic placode pax2a expression decreased distribution, abnormal
Gou et al., 2018	Fig. 2		sox3x52/x52 (AB)	statoacoustic (VIII) ganglion neuron decreased amount, abnormal
Hong et al., 2018	Fig. 1		sox3whu101/whu101 ,   sox3whu102/whu102	ovary sox3 expression absent, abnormal ovary sox3 expression decreased amount, abnormal
	Figure 2		sox3whu101/whu101 ,   sox3whu102/whu102	female organism decreased fecundity, abnormal ovarian follicle development delayed, abnormal ovarian follicle stage III decreased amount, abnormal ovarian follicle stage IV decreased amount, abnormal
	Figure 4		sox3whu101/whu101 ,   sox3whu102/whu102	granulosa cell apoptotic process increased occurrence, abnormal oocyte stage III apoptotic process increased occurrence, abnormal oocyte stage IV apoptotic process increased occurrence, abnormal ovary boka expression increased amount, abnormal ovary capn12 expression increased amount, abnormal ovary casp3a expression increased amount, abnormal ovary pmaip1 expression increased amount, abnormal ovary tspo expression increased amount, abnormal ovary Ab19-casp3 labeling increased amount, abnormal theca cell apoptotic process increased occurrence, abnormal
	Figure 5		sox3whu101/whu101 ,   sox3whu102/whu102	ovary 17beta-estradiol decreased amount, abnormal ovary cyp19a1a expression decreased amount, abnormal testis 17beta-estradiol decreased amount, abnormal
Padanad et al., 2011	Fig. 2		AB + MO3-sox3	epibranchial ganglion decreased amount, abnormal
Dee et al., 2008	Fig. 5		WT + MO1-sox3 + MO2-sox3	central nervous system development disrupted, abnormal
	Fig. 6		WT + MO1-sox3 + MO2-sox3	brain apoptotic, abnormal brain decreased size, abnormal brain morphology, abnormal brain nucleus decreased amount, abnormal central canal unlumenized, abnormal central nervous system apoptotic, abnormal central nervous system development disrupted, abnormal eye decreased size, abnormal roof plate rhombomere region left-right axis decreased width, abnormal spinal cord nucleus decreased amount, abnormal whole organism decreased length, abnormal
	Fig. 7		WT + MO1-sox3 + MO2-sox3	central nervous system development disrupted, abnormal whole organism decreased length, abnormal
	Fig. 8		WT + MO1-sox3 + MO2-sox3	neuron differentiation disrupted, abnormal
	Fig. 9		WT + MO1-sox3 + MO2-sox3	neurogenic placode morphology, abnormal neuron differentiation disrupted, abnormal otic vesicle aplastic, abnormal otic vesicle decreased size, abnormal otic vesicle morphology, abnormal